xcellbio Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

Xcellbio develops and commercializes technology platforms, instruments, and software to support cell and gene therapy research. Its work aims to improve the performance and safety of these therapies by enabling researchers to gain insights into immune and tumor biology and by enabling translation to patient-scale manufacturing through a cGMP-compliant cell therapy platform. The company operates from bases in Melbourne and San Francisco.

In the biotechnology research sector, its customers include researchers and institutions working on cell and gene therapies who rely on its tools to generate new biological insights and facilitate translation into therapies. In June 2025, the company announced a partnership with Thermo Fisher Scientific to advance research in regulatory T cells and tumor-infiltrating lymphocytes. The organization is mid-sized, with a footprint spanning its two bases.

Sign up for free to view info

Company overview Employee directory